Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like The fear of loss can cost investors big-time. Here’s how House approves tentative labor deal to avoid rail strike, sends to Senate Biden administration loosens Trump-era investing rules around environment, social and governance funds for 401(k) plans Disney hiring freeze will stay in place, CEO Bob Iger tells employees It’s been a volatile year for the market: These are the key things to know before rebalancing your portfolio
